Showing results (181-190 of 203) with videos related to
Sort By:
Pageof 21
European Journal of Cancer (Oxford, England : 1990)|October 31, 2025
International expert consensus on the clinical integration of circulating tumor cells in solid tumorsEleonora Nicolò, Carolina Reduzzi, Jean-Yves Pierga, et al.Journal of Cancer|April 19, 2018
Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary ConferenceWendy A Woodward, Massimo Cristofanilli, Sofia D Merajver, et al.Journal of Cancer|May 4, 2018
International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary ConferenceNaoto T Ueno, Jose Rodrigo Espinosa Fernandez, Massimo Cristofanilli, et al.Annals of Surgery|May 27, 2017
A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic TherapyHenry M Kuerer, Gaiane M Rauch, Savitri Krishnamurthy, et al.Annals of Surgical Oncology|March 16, 2026
Real-World Outcomes for Patients with Clinically Node-Positive Melanoma Undergoing Neoadjuvant Immunotherapy and Nodal DissectionJoshua Herb, Roland L Bassett, Carlos A Torres-Cabala, et al.JCO Precision Oncology|March 16, 2022
Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic ChemotherapyHiroko Masuda, Kenichi Harano, Sakiko Miura, et al.JAMA Oncology|June 8, 2018
Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast CancerNaoko Matsuda, Xiaoping Wang, Bora Lim, et al.BMC Cancer|September 21, 2018
Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modelingSweet Ping Ng, Houda Bahig, Jihong Wang, et al.Current Oncology (Toronto, Ont.)|October 28, 2025
Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1aAtilla Soran, Berk Göktepe, Berkay Demirors, et al.Journal of the National Cancer Institute|November 9, 2014
Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer researchMartine Moossdorff, Lori M van Roozendaal, Luc J A Strobbe, et al.Pageof 21